新型冠状病毒抗原表位融合蛋白的设计制备及免疫特性研究

药物生物技术 Pub Date : 2022-02-15 DOI:10.19526/j.cnki.1005-8915.20220101

庄素素 | 李巍 | 沈万鹏 | 李佳萌 | 郐启源 | 徐应佳 | 赵楠 | 李越希

引用次数: 0

查看原文本刊更多论文

新型冠状病毒抗原表位融合蛋白的设计制备及免疫特性研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

药物生物技术 Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

CiteScore

0.10

自引率

0.00%

发文量

期刊介绍： Pharmaceutical Biotechnology was founded in 1994. It is a national academic journal jointly sponsored by China Pharmaceutical University, China Medical Science and Technology Press and Chinese Pharmaceutical Association. It is a bimonthly, 16-mo, 112-page journal, and is publicly distributed at home and abroad. The domestic unified journal number is CN32-1488/R, and the international journal number is ISSN 1005-8915. It is a core journal of Chinese pharmacy and biology. This journal mainly publishes the latest research results and application progress of modern biotechnology in medicine and health, chemistry, food industry, agriculture and other related fields. It is an important window for domestic and foreign exchanges of innovative research in the fields of genetic engineering, protein engineering, cell engineering, enzyme engineering, fermentation engineering, etc.; the journal embodies the characteristics of academic, scientific, authoritative, cutting-edge and strong readability.